<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=ACO2</id>
	<title>ACO2 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=ACO2"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=ACO2&amp;action=history"/>
	<updated>2026-08-10T14:47:03Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=ACO2&amp;diff=4148&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Aconitate hydratase, mitochondrial precursor (EC 4.2.1.3) (Aconitase) (Citrate hydro-lyase)  ==Publications==  {{medline-entry |title=Thioredoxin protects mitocho...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=ACO2&amp;diff=4148&amp;oldid=prev"/>
		<updated>2021-04-29T19:03:06Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Aconitate hydratase, mitochondrial precursor (EC 4.2.1.3) (Aconitase) (Citrate hydro-lyase)  ==Publications==  {{medline-entry |title=Thioredoxin protects mitocho...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Aconitate hydratase, mitochondrial precursor (EC 4.2.1.3) (Aconitase) (Citrate hydro-lyase)&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Thioredoxin protects mitochondrial structure, function and biogenesis in myocardial ischemia-reperfusion via redox-dependent activation of AKT-CREB- PGC1α pathway in aged mice.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33049718&lt;br /&gt;
|abstract=Aging is an independent risk factor for cardiovascular diseases, such as myocardial infarction due to ischemia-reperfusion injury (I/R) of the heart. Cytosolic thioredoxin (Trx) is a multifunctional redox protein which has antioxidant and protein disulfide reducing properties. We hypothesized that high levels of Trx will protect against multifactorial disease such as myocardial infarction due to I/R injury in aged mice. Aged mice overexpressing human Trx ([i]Trx-Tg[/i]), mice expressing redox-inactive mutant of human Trx ([i]dnTrx-Tg[/i]) and non-transgenic litter-mates ([i]NT)[/i] were subjected to I/R (60/30 min), and cardiac function, mitochondrial structure and function, and biogenesis involving PGC1α pathway were evaluated in these mice. While aged [i]Trx-Tg[/i] mice were protected from I/R-induced reduction in ejection fraction (EF) and fractional shortening (FS), had smaller infarct with decreased apoptosis and preserved mitochondrial function, aged [i]dnTrx-Tg[/i] mice showed enhanced myocardial injury and mitochondrial dysfunction. Further, [i]Trx-Tg[/i] mice were protected from I/R induced loss of PGC1α, [[ACO2]], [[MFN1]] and [[MFN2]] in the myocardium. The [i]dnTrx-Tg[/i] mice were highly sensitive to I/R induced apoptosis. Overall, our study demonstrated that the loss of Trx redox balance in I/R in aged [i]NT[/i] or [i]dnTrx-Tg[/i] mice resulted in decreased PGC1α expression that decreased mitochondrial gene expression with increased myocardial apoptosis. High levels of Trx, but not mitochondrial thioredoxin (Trx-2) maintained Trx redox balance in I/R resulting in increased PGC1α expression via AKT/CREB activation upregulating mitochondrial gene expression and protection against I/R injury.&lt;br /&gt;
&lt;br /&gt;
|keywords=* aging&lt;br /&gt;
* heart&lt;br /&gt;
* ischemia-reperfusion&lt;br /&gt;
* mitochondria&lt;br /&gt;
* thioredoxin&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.18632/aging.104071&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>